Neutral
ETFs Investing in Insulet Corporation Stocks
This article lists various Exchange Traded Funds (ETFs) that hold stocks of Insulet Corporation (GOV). It provides a detailed table including fund nam...
PODD
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (14)
Neutral (11)
Bearish (3)
Latest PODD News
Bullish
Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care
Insulet Corporation announced new clinical results for its Omnipod® 6 and fully closed-loop (FCL) system for type 2 diabetes, presented at the America...
Bullish
Insulin pump trials: Omnipod 6 lifts time in range with fewer boluses
Insulet Corporation announced new clinical data from the STRIVE pivotal trial and EVOLUTION 3 feasibility study, demonstrating significant improvement...
Neutral
PODD Stock Balances Device Setback With Omnipod Upgrade Momentum
Insulet Corporation (PODD) stock is showing an uptrend despite a recent voluntary global medical device correction affecting millions of pods due to a...
Neutral
Independent Chair of Insulet Picks Up 66% More Stock
Insulet's Independent Chair, Elizabeth Weatherman, recently purchased US$497k worth of company stock at US$144 per share, increasing her holding by 66...
Bullish
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions
Insulet Corporation announced its plans for the American Diabetes Association's 86th Scientific Sessions, highlighting new data and innovations for it...
Bullish
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions
Insulet Corporation announced its plans for the American Diabetes Association's 86th Scientific Sessions, where it will showcase new data and innovati...
Bullish
Insulet's Omnipod 5 Update: A Masterclass in Personalized Health Tech
Insulet Corporation has launched significant enhancements for its Omnipod 5 Automated Insulin Delivery (AID) System, including a new 100 mg/dL target ...
Bullish
Insulet Rolls Out New Omnipod 5 Algorithm, Compatibility with Abbott’s FreeStyle Libre 3 Plus
Insulet has launched new algorithm enhancements for its Omnipod 5 automated insulin delivery system, including a 100 mg/dL Target Glucose option for g...
Bullish
New Omnipod 5 update lets U.S. users aim for 100 mg/dL, use Libre 3 Plus
Insulet Corporation has announced the U.S. rollout of enhanced Omnipod 5 algorithm updates, allowing users to aim for a 100 mg/dL target glucose and i...
Bullish
5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
Insulet Corporation announced the U.S. rollout of an enhanced Omnipod 5 Automated Insulin Delivery (AID) System algorithm and expanded compatibility w...
Neutral
Court overturns Insulet’s $59M trade secret verdict against EOFlow
A U.S. appeals court has overturned a $59.4 million trade secret award to Insulet against rival insulin pump company EOFlow. The court ruled that Insu...
Bearish
TD Cowen Adjusts Insulet Price Target to $294 From $379, Maintains Hold Rating
TD Cowen has revised its price target for Insulet (NASDAQ: PODD) from $379 to $294, while keeping a "Hold" rating on the stock. This adjustment comes ...
Bearish
US appeals court overturns Insulet's $59 million (not $452 mln) insulin-pump trade secret verdict against rival Eoflow | MarketScreener
A US appeals court has overturned a $59 million trade secret verdict that Insulet Corporation had won against its rival Eoflow regarding insulin-pump ...
Bearish
Insulet’s $59 Million Trade Secrets Award Voided by Court
A federal court has voided a $59.4 million trade secrets award that Insulet Corp. initially won against EOFlow Co. Ltd. The court ruled that Insulet f...
Neutral
Insulet Corporation stock hits 52-week low at $143.95 By Investing.com
Insulet Corporation's stock has dropped to a 52-week low of $143.95, reflecting a challenging year with a 52.46% decline. Despite this, InvestingPro d...
Neutral
Insulet recalls 7M patch pumps due to leak risk
Insulet has issued a recall for 7 million insulin patch pumps across its Omnipod 5, Omnipod DASH, and Omnipod Insulin Management System devices. This ...
Neutral
Here’s Insiders Fund’s Thesis on Insulet Corporation (PODD)
Alpha Wealth Funds, LLC's "Insiders Fund" discussed Insulet Corporation (NASDAQ:PODD) in its Q1 2026 investor letter. While the fund acknowledged PODD...
Bullish
William Blair initiates Insulet stock coverage with Outperform rating By Investing.com
William Blair has initiated coverage on Insulet Corporation (NASDAQ:PODD) with an Outperform rating, noting the stock is undervalued compared to peers...
Bullish
William Blair Assumes Insulet Corporation (PODD) at Outperform
William Blair analyst Steve Lichtman initiated coverage on Insulet Corporation (PODD) with an Outperform rating. The article, however, is premium cont...
Research PODD on:
Ad Space